Maverix Biomics
Pioneering a seamless, open, and cloud-based platform that empowers researchers with superior bioinformatics tools and comprehensive genomic data integration.
Pioneering a seamless, open, and cloud-based platform that empowers researchers with superior bioinformatics tools and comprehensive genomic data integration.
Maverix Biomics, founded in 2012, operates in the Biotechnology industry with a focus on providing a seamless, open, and cloud-based platform for researchers. The company received a $6.00M Series A investment on 07 January 2014 from Asset Management Ventures, VKRM Ventures, and Andrew Yang. Maverix Biomics brings together expertise in biologic research, bioinformatics, and enterprise application software development, leveraging the knowledge of leading research institutions and technology companies. The company's team, which includes leaders from successful Silicon Valley enterprises and top-tier researchers from the University of California, Santa Cruz, is committed to empowering research scientists with superior bioinformatics tools and comprehensive genomic data integration. Their platform aims to integrate superior open-source software, anticipate user needs, foster communities of discovery, and contextualize data with the most recent biomic information for various genomes, including viral, bacterial, vertebrate, and plant genomes.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $6.00M | 3 |
|
07 Jan 2014 |
| Venture Round | $7.99M | - | 18 Dec 2013 |
No recent news or press coverage available for Maverix Biomics.
We care about your data, and we'd love to use cookies make your experience better.
